查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1751518

动物保健单株抗体市场规模、份额、趋势分析报告：按应用、动物类型、最终用户、地区、细分预测，2025-2030 年

Monoclonal Antibodies In Veterinary Health Market Size, Share & Trends Analysis Report By Application (Dermatology, Pain), By Animal Type (Dogs), By End User (Veterinary Hospitals), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

动物保健单株抗体市场的成长与趋势：

根据 Grand View Research, Inc. 的一份新报告，全球动物保健单株抗体市场预计到 2030 年将达到 33 亿美元，2025 年至 2030 年的复合年增长率为 19.1%。

宠物数量的增长以及宠物消费的增加预计将推动市场成长。此外，犬异位性皮肤炎的盛行率上升也可能在预测期内推动市场成长。

儘管新冠疫情造成了衝击，动物用药品产业在2019年至2020年期间仍实现了8%的稳定成长。与其他市场相比，经济衰退对动物用药品产业的影响相对较小。疫情也为动物医院和兽医的经营模式带来了许多变化。预计传统动物医院的大部分收益将来自生技药品和药品等高利润产品的销售。

癌症发生率的上升，尤其是在犬类中，预计将为市场的成长奠定基础。根据美国兽医协会 (AVMA) 的数据，预计四分之一的犬隻在其一生中的某个阶段会出现肿瘤的征兆。肿瘤是犬类常见的一种癌症。疼痛管理是治疗犬类肿瘤最重要的方面之一，单株抗体也可以治疗肿瘤。

市场竞争激烈，大型企业林立。随着市场涌现巨大的机会，各家企业纷纷加大投资，力求成为产业领导者。例如，硕腾公司于2021年10月在爱尔兰收购了一家新的研发和生产部门，以提升其兽用单株抗体（mAb）的生产能力。

此举预计将增强礼来在动物治疗生物製药领域的产品组合。此外，礼来于2021年8月以约4.44亿美元收购了Kindred Biosciences，此举有助于礼来进军皮肤病学市场，补充产品平臺，并增强其在生技药品和单株抗体领域的研发能力。

此外，Elanco于2023年5月宣布，该公司使用单株抗体研发出突破性的致命犬小病毒病治疗方法。这种单次静脉注射可治疗病犬和幼犬的细小病毒症状，无论它们是否接种过疫苗。

动物保健单株抗体市场报告重点

  • 根据动物类型，预计到 2024 年，狗类市场将占据绝大部分收入，这归因于人们越来越多地将狗作为宠物饲养，以及针对犬类疾病治疗的研究和开发不断增加。
  • 根据应用，由于犬类异位性皮肤炎盛行率不断上升，皮肤病学领域将在 2024 年占据最大的市场占有率，超过 51.31%。
  • 根据最终用途，由于兽医院拥有先进的治疗设施，兽部门在 2024 年占据了主导市场占有率。
  • 由于该地区有大型市场公司，预计到 2024 年北美将占据最大的市场占有率，约 43.775%。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

  • 市场展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 产业分析
    • 波特五力分析
    • 佩斯特尔
  • 法律规范
  • 产品平臺分析
  • 定价分析
  • COVID-19影响分析

第四章动物保健单株抗体市场：按动物类型估计和趋势分析

  • 细分仪表板
  • 动物保健单株抗体市场：2024 年和 2030 年动物类型差异分析
  • 狗
  • 其他的

第五章动物保健单株抗体市场：应用评估与趋势分析

  • 细分仪表板
  • 动物保健单株抗体市场：2024 年和 2030 年应用趋势分析
  • 皮肤科市场
  • 疼痛
  • 其他的

第六章动物保健单株抗体市场：最终用户估计和趋势分析

  • 动物保健单株抗体市场：2024 年和 2030 年最终用户差异分析
  • 兽医诊所
  • 其他的

第七章动物保健单株抗体市场：区域估计与趋势分析

  • 动物保健单株抗体市场：2024 年和 2030 年区域差异分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 市场参与企业分类
  • 企业市场分析/堆图分析
  • 公司简介
    • Zoetis Inc.
    • Boehringer Ingelheim Gmbh
    • Merck &Co., Inc.
    • Elanco
    • Virbac SA
    • Indian Immunologicals Ltd
  • 战略地图
    • 合併与收购
    • 伙伴关係和合作
    • 扩张
    • 产品发布
    • 产品核可
    • 其他的
  • List of Other Players

第九章 重点

Product Code: GVR-4-68039-973-5

Monoclonal Antibodies In Veterinary Health Market Growth & Trends:

The global monoclonal antibodies in veterinary health market size is estimated to reach USD 3.30 billion by 2030, expanding at a CAGR of 19.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing pet population coupled with the rising pet expenditure is expected to boost the market growth. Furthermore, the growing prevalence of canine atopic dermatitis will likely drive market growth over the forecast period.

Despite disruption due to the COVID-19 pandemic, the animal health industry witnessed a steady growth of 8% from 2019 to 2020. The economic downturn was relatively less impactful in the animal health industry compared to other markets. The pandemic created a few shifts in business models for veterinary practices and veterinarians. Traditional veterinary practices are expected to generate the most revenue from selling high-margin products like biologics and pharmaceuticals.

The growing incidences of cancer, especially in dogs, are anticipated to provide a growth platform for the market. According to the American Veterinary Medical Association (AVMA), around 1 out of every 4 dogs are expected to show signs of neoplasia at some point in their lives. Neoplasia is a common type of cancer in dogs. Pain management is one of the most important aspects of treating neoplasia in dogs. This can also be treated using the monoclonal antibody treatment.

The market is highly competitive and consists of several major players. With the emergence of immense opportunities in the market, various players in the market are making investments to emerge as leading players. For instance, in October 2021, Zoetis acquired a new development and manufacturing unit in Ireland to improve its production capabilities on veterinary Monoclonal Antibodies (mAbs).

This is anticipated to enhance its veterinary therapeutic biopharmaceuticals portfolio. Moreover, in August 2021, Elanco acquired Kindred Biosciences for approximately USD 444 million. This supported the company's access to the dermatology market, complemented its product pipeline, and enhanced R&D capabilities in biologics and monoclonal antibodies.

In addition, in May 2023, Elanco announced its breakthrough treatment for deadly canine parvovirus diseases using monoclonal antibodies. This single intravenous dose treats the signs caused by parvovirus in sick dogs and puppies regardless of their vaccination status.

Monoclonal Antibodies In Veterinary Health Market Report Highlights:

  • Based on animal type, the dog segment held the dominant revenue share in 2024 owing to the growing adoption of dogs as pets and increasing R&D targeting canine disease treatments
  • Based on the application, the dermatology segment accounted for the largest market share of over 51.31% in 2024, owing to the increasing prevalence of canine atopic dermatitis
  • The veterinary hospital segment accounted for a dominant market share in terms of end-user in 2024, owing to the availability of advanced treatment facilities in veterinary hospitals
  • The North America accounted for the largest market share of around 43.775% in 2024, owing to the presence of major market players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
    • 1.2.1. Information Procurement
  • 1.3. Information or Data Analysis
  • 1.4. General Methodology
  • 1.5. Research Scope & Assumptions
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Bottom-Up & Hybrid Model
    • 1.7.3. CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Industry Analysis
    • 3.3.1. Porter's
    • 3.3.2. PESTEL
  • 3.4. Regulatory Framework
  • 3.5. Product Pipeline Analysis
  • 3.6. Pricing Analysis
  • 3.7. COVID-19 Impact Analysis

Chapter 4. Monoclonal Antibodies In Veterinary Health Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Monoclonal Antibodies In Veterinary Health Market: Animal Type Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Dogs
    • 4.3.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Monoclonal Antibodies In Veterinary Health Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Monoclonal Antibodies In Veterinary Health Market: Application Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Dermatology Market
    • 5.3.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Pain
    • 5.4.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Monoclonal Antibodies In Veterinary Health Market: End User Estimates & Trend Analysis

  • 6.1. Monoclonal Antibodies In Veterinary Health Market: End User Movement Analysis, 2024 & 2030 (USD Million)
  • 6.2. Veterinary Hospitals
    • 6.2.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Others
    • 6.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Monoclonal Antibodies In Veterinary Health Market: Regional Estimates & Trend Analysis

  • 7.1. Monoclonal Antibodies In Veterinary Health Market: Regional Movement Analysis, 2024 & 2030
  • 7.2. North America
    • 7.2.1. North America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. U.S. Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Canada Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Mexico Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. UK Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Germany Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. France Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Italy Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Spain Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Sweden
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Sweden Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Denmark Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Norway Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. China Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Japan Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. India Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Australia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. South Korea Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Thailand Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Brazil Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Argentina Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East & Africa
    • 7.6.1. Middle East & Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. South Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Saudi Arabia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. UAE Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Kuwait Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Position Analysis/ Heap Map Analysis
  • 8.3. Company Profiles
    • 8.3.1. Zoetis Inc.
      • 8.3.1.1. Participant's Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Boehringer Ingelheim Gmbh
      • 8.3.2.1. Participant's Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Merck & Co., Inc.
      • 8.3.3.1. Participant's Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Elanco
      • 8.3.4.1. Participant's Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Virbac S.A.
      • 8.3.5.1. Participant's Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Indian Immunologicals Ltd
      • 8.3.6.1. Participant's Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
  • 8.4. Strategy Mapping
    • 8.4.1. Mergers & Acquisitions
    • 8.4.2. Partnerships & Collaborations
    • 8.4.3. Expansion
    • 8.4.4. Product launch
    • 8.4.5. Product Approval
    • 8.4.6. Others
  • 8.5. List of Other Players

Chapter 9. Key Takeaways

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Global Monoclonal Antibodies In Veterinary Health Market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 5 Global Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 6 North America Monoclonal Antibodies In Veterinary Health Market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 8 North America Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 9 North America Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 10 U.S. Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 13 Canada Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 14 Canada Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 15 Canada Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 16 Europe Monoclonal Antibodies In Veterinary Health Market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 19 Europe Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 20 UK Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 22 UK Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 23 Germany Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 24 Germany Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 25 Germany Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 26 France Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 27 France Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 28 France Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 29 Italy Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 30 Italy Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 31 Italy Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 32 Spain Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 33 Spain Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 34 Spain Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 35 Denmark Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 36 Denmark Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 37 Denmark Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 38 Sweden Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 39 Sweden Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 40 Sweden Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 41 Norway Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 42 Norway Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 43 Norway Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 48 Japan Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 49 Japan Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 50 Japan Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 51 China Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 52 China Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 53 China Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 54 India Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 55 India Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 56 India Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 57 South Korea Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 59 South Korea Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 60 Australia Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 62 Australia Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 63 Thailand Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 64 Thailand Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 65 Thailand Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 66 Latin America Monoclonal Antibodies In Veterinary Health Market, by country, 2018 - 2030 (USD Million)
  • Table 67 Latin America Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 68 Latin America Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 69 Latin America Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 70 Brazil Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 71 Brazil Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 72 Brazil Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 73 Mexico Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 74 Mexico Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 75 Mexico Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 76 Argentina Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 77 Argentina Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 79 MEA Monoclonal Antibodies In Veterinary Health Market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 81 MEA Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 82 MEA Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 83 South Africa Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 89 UAE Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 91 UAE Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 95 Participant's overview
  • Table 96 Financial performance
  • Table 97 Indication/ Services benchmarking
  • Table 98 Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 Monoclonal Antibodies In Veterinary Health Market revenue, 2018-2030 (USD Million)
  • Fig. 10 Monoclonal Antibodies In Veterinary Health Market Snapshot
  • Fig. 11 Monoclonal Antibodies In Veterinary Health Market driver impact
  • Fig. 12 Monoclonal Antibodies In Veterinary Health Market restraint impact
  • Fig. 13 Porter's 5 Forces Analysis
  • Fig. 14 PESTEL Analysis
  • Fig. 15 Monoclonal Antibodies In Veterinary Health Market Animal Type key takeaways (USD Million)
  • Fig. 16 Monoclonal Antibodies In Veterinary Health Market: Animal Type movement analysis
  • Fig. 17 Dogs market, 2018 - 2030 (USD Million)
  • Fig. 18 Other animals market, 2018 - 2030 (USD Million)
  • Fig. 19 Monoclonal Antibodies In Veterinary Health Market Application key takeaways (USD Million)
  • Fig. 20 Monoclonal Antibodies In Veterinary Health Market: Application movement analysis
  • Fig. 21 Dermatology market, 2018 - 2030 (USD Million)
  • Fig. 22 Pain market, 2018 - 2030 (USD Million)
  • Fig. 23 Others market, 2018 - 2030 (USD Million)
  • Fig. 24 Monoclonal Antibodies In Veterinary Health Market End user key takeaways (USD Million)
  • Fig. 25 Monoclonal Antibodies In Veterinary Health Market: End user movement analysis
  • Fig. 26 Veterinary Hospitals & Clinics market, 2018 - 2030 (USD Million)
  • Fig. 27 Other end user market, 2018 - 2030 (USD Million)
  • Fig. 28 Regional market place: Key takeaways
  • Fig. 29 Regional Outlook, 2024 & 2030
  • Fig. 30 North America Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 32 Canada Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 35 UK Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 37 France Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 38 Italy Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 39 Spain Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 42 Norway Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 44 Japan Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 45 China Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 46 India Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 47 South Korea Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 48 Australia Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 53 MEA Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 54 South Africa Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 56 UAE Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 58 Market participant categorization
  • Fig. 59 Heat map analysis
  • Fig. 60 Strategy Mappings